Efficacy and Safety of Anti-Interleukin-17A Monoclonal Antibody Secukinumab in Treatment of Ankylosing Spondylitis: A Meta-Analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and Safety of Anti-Interleukin-17A Monoclonal Antibody Secukinumab in Treatment of Ankylosing Spondylitis: A Meta-Analysis

Published:2020-10-01 Issue:5 Volume:39 Page:160-166
ISSN:2167-9436
Container-title:Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
language:en
Short-container-title:Monoclonal Antibodies in Immunodiagnosis and Immunotherapy

Author:

Katsevman Gennadiy A.¹,Mariscal Gonzalo²,Barrios Carlos²,Domenech-Fernández Pedro²,Ziembinski Conrad³,Bhatia Sanjay¹

Affiliation:

1. Department of Neurosurgery, West Virginia University, Morgantown, West Virginia, USA.

2. Institute for Research on Musculoskeletal Disorders, Valencia Catholic University, Valencia, Spain.

3. Department of Rheumatology, Larkin Community Hospital, South Miami, Florida, USA.

Publisher

Mary Ann Liebert Inc

Subject

Immunology,Immunology and Allergy

Link

https://www.liebertpub.com/doi/pdf/10.1089/mab.2020.0022

Reference17 articles.

1. Epidemiology of Spondyloarthritis in the People’s Republic of China: Review of the Literature and Commentary

2. Ankylosing Spondylitis and Axial Spondyloarthritis

3. Ischemic heart disease and ankylosing spondylitis—assessing the role of inflammation

4. Comorbidity burden in axial spondyloarthritis: a cluster analysis

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PSORIATIC ARTHRITIS: PROBLEMS AND SOLUTIONS (CASE REPORT);Acta medica Eurasica;2023-12-27

2. Comparative Pharmacoeconomic Effectiveness of Interleukin-17 Inhibitors for the Treatment of Ankylosing Spondylitis;Doklady Biochemistry and Biophysics;2023-08

3. Overview of Research on the Treatment of Ankylosing Spondylitis in Chinese Medicine;Journal of Biosciences and Medicines;2023

4. Comparative pharmacoeconomic effectiveness of interleukin-17 inhibitors for the treatment of ankylosing spondylitis;Rheumatology Science and Practice;2022-12-25

5. Treating Psoriatic Arthritis By TNF –Α Inhibitors: A Case Study;International Journal of Life Science and Pharma Research;2022-07-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3